Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Bisabolene compound extracted from cassia fistula and docked as antioxidant and vitamin E alternative predicted drug design

Breadcrumb

  • Home
  • Bisabolene Compound Extracted From Cassia Fistula and Docked As Antioxidant and Vitamin E Alternative Predicted Drug Design
  • Bisabolene compound extracted from cassia fistula and docked as antioxidant and vitamin E alternative predicted drug design

Inas Osman Khojali 1, * and Mohammed Yousif Mohammed 2

1 Department of Chemistry and Industrial Chemistry, College of Applied and Industrial Sciences, University of Bahri, Sudan.
2 Department of Biology, College of Applied and Industrial Sciences, University of Bahri, Sudan.
 
Research Article
GSC Advanced Research and Reviews, 2023, 15(01), 069–075.
Article DOI: 10.30574/gscarr.2023.15.1.0111
DOI url: https://doi.org/10.30574/gscarr.2023.15.1.0111
Received on 24 February 2023, revised on 10 April 2023, accepted on 13 April 2023
 
Cis-Z-alpha-bisabolene epoxide (bisabolene) compound is extracted from Cassia fistula plant bark, which is a medicinal tree that contains many useful drug substances, the compound can act as a drug predictably similar to vitamin E, with the same function as an antioxidant which can act on pregnane X receptor on the body cells. The gas chromatography-mass spectrometry (GC-MS) analysis was used to identify the constituents of the n-hexane extract. Drug Bank was used to find similar compounds. The ID of the pregnane x receptor (PXR) was retrieved from the PDB database. Then the bisabolene ligand was used for docking with the receptor using Swiss Dock. Finally, the Swiss ADME was used to study and predict the pharmacological parameters. It was found that bisabolene can act as an antioxidant and alternative to vitamin E in the pregnane x receptor and with good pharmacological predicted results. When bisabolene is used as an effective ligand with pregnane X receptor alternative to vitamin E, care must be taken because the compound can penetrate the blood-brain barrier (BBB) with a specific amount.
 
Cassia fistula; GC-MS analysis; Cis-Z-alpha- bisabolene epoxide; Pregnane X receptor; Swiss Dock; Swiss ADME
 
https://gscarr.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCARR-2023-…

Preview Article PDF

Inas Osman Khojali and Mohammed Yousif Mohammed. Bisabolene compound extracted from cassia fistula and docked as antioxidant and vitamin E alternative predicted drug design. GSC Advanced Research and Reviews, 2023, 15(1), 069-075. Article DOI: https://doi.org/10.30574/gscarr.2023.15.1.0111

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution